Tartrate-resistant acid phosphatase 5a in sarcoidosis: Further evidence for a novel macrophage biomarker in chronic inflammation

Yi Ying Wu, Anthony J. Janckila, Stephen P. Slone, Wann Cherng Perng, Tsu Yi Chao

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background/Purpose: Tartrate-resistant acid phosphatase (TRACP) 5a is expressed strongly in inflammatory macrophages (MΦ). Serum TRACP5a is elevated in rheumatoid arthritis patients with extra-articular manifestations of rheumatoid nodules, in a percentage of patients with end-stage chronic kidney disease, and may be a risk marker for acute myocardial infarction. This proof-of-concept study was undertaken in patients with sarcoidosis to further substantiate our hypothesis that TRACP5a protein is a biomarker for macrophages in other chronic inflammatory diseases. Methods: Immunohistochemical staining for TRACP5a and CD68 was performed in tissues of 19 patients with sarcoidosis. We also measured circulating TRACP5a protein and other inflammation biomarkers including interkeukin-6, angiotensin-converting enzyme, and C-reactive protein in 13 patients. Twenty healthy age-matched nonsmoking individuals were used as the reference group. Results: All sarcoidosis tissues showed strong staining for TRACP5a and CD68 in the non-caseating granulomatous lesions and localized specifically to MΦ, multinucleate giant cells, and epithelioid MΦ. Serum TRACP5a protein was elevated significantly in active sarcoidosis patients compared with the control group, and levels fluctuated with disease activity in one patient studied longitudinally. Conclusion: TRACP5a protein is expressed abundantly in the granulomatous tissues and may be elevated in a significant proportion of sarcoidosis patients. These findings further support our hypothesis that serum TRACP5a is derived from systemic inflammatory MΦ and thereby may be a biomarker of inflammation for sarcoidosis and also reflect its disease activity.

Original languageEnglish
Pages (from-to)364-370
Number of pages7
JournalJournal of the Formosan Medical Association = Taiwan yi zhi
Volume113
Issue number6
DOIs
Publication statusPublished - 2014

Fingerprint

Sarcoidosis
Biomarkers
Macrophages
Inflammation
Rheumatoid Nodule
Staining and Labeling
Proteins
Tartrate-Resistant Acid Phosphatase
Peptidyl-Dipeptidase A
Giant Cells
Serum
Chronic Renal Insufficiency
C-Reactive Protein
Chronic Kidney Failure
Blood Proteins
Rheumatoid Arthritis
Chronic Disease
Joints
Myocardial Infarction
Control Groups

Keywords

  • Inflammation
  • Macrophage
  • Sarcoidosis
  • Tartrate-resistant acid phosphatase 5a

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Tartrate-resistant acid phosphatase 5a in sarcoidosis : Further evidence for a novel macrophage biomarker in chronic inflammation. / Wu, Yi Ying; Janckila, Anthony J.; Slone, Stephen P.; Perng, Wann Cherng; Chao, Tsu Yi.

In: Journal of the Formosan Medical Association = Taiwan yi zhi, Vol. 113, No. 6, 2014, p. 364-370.

Research output: Contribution to journalArticle

@article{5307c57153314b479d675fdb039ceb5e,
title = "Tartrate-resistant acid phosphatase 5a in sarcoidosis: Further evidence for a novel macrophage biomarker in chronic inflammation",
abstract = "Background/Purpose: Tartrate-resistant acid phosphatase (TRACP) 5a is expressed strongly in inflammatory macrophages (MΦ). Serum TRACP5a is elevated in rheumatoid arthritis patients with extra-articular manifestations of rheumatoid nodules, in a percentage of patients with end-stage chronic kidney disease, and may be a risk marker for acute myocardial infarction. This proof-of-concept study was undertaken in patients with sarcoidosis to further substantiate our hypothesis that TRACP5a protein is a biomarker for macrophages in other chronic inflammatory diseases. Methods: Immunohistochemical staining for TRACP5a and CD68 was performed in tissues of 19 patients with sarcoidosis. We also measured circulating TRACP5a protein and other inflammation biomarkers including interkeukin-6, angiotensin-converting enzyme, and C-reactive protein in 13 patients. Twenty healthy age-matched nonsmoking individuals were used as the reference group. Results: All sarcoidosis tissues showed strong staining for TRACP5a and CD68 in the non-caseating granulomatous lesions and localized specifically to MΦ, multinucleate giant cells, and epithelioid MΦ. Serum TRACP5a protein was elevated significantly in active sarcoidosis patients compared with the control group, and levels fluctuated with disease activity in one patient studied longitudinally. Conclusion: TRACP5a protein is expressed abundantly in the granulomatous tissues and may be elevated in a significant proportion of sarcoidosis patients. These findings further support our hypothesis that serum TRACP5a is derived from systemic inflammatory MΦ and thereby may be a biomarker of inflammation for sarcoidosis and also reflect its disease activity.",
keywords = "Inflammation, Macrophage, Sarcoidosis, Tartrate-resistant acid phosphatase 5a",
author = "Wu, {Yi Ying} and Janckila, {Anthony J.} and Slone, {Stephen P.} and Perng, {Wann Cherng} and Chao, {Tsu Yi}",
year = "2014",
doi = "10.1016/j.jfma.2012.07.033",
language = "English",
volume = "113",
pages = "364--370",
journal = "Journal of the Formosan Medical Association",
issn = "0929-6646",
publisher = "Elsevier Science Publishers B.V.",
number = "6",

}

TY - JOUR

T1 - Tartrate-resistant acid phosphatase 5a in sarcoidosis

T2 - Further evidence for a novel macrophage biomarker in chronic inflammation

AU - Wu, Yi Ying

AU - Janckila, Anthony J.

AU - Slone, Stephen P.

AU - Perng, Wann Cherng

AU - Chao, Tsu Yi

PY - 2014

Y1 - 2014

N2 - Background/Purpose: Tartrate-resistant acid phosphatase (TRACP) 5a is expressed strongly in inflammatory macrophages (MΦ). Serum TRACP5a is elevated in rheumatoid arthritis patients with extra-articular manifestations of rheumatoid nodules, in a percentage of patients with end-stage chronic kidney disease, and may be a risk marker for acute myocardial infarction. This proof-of-concept study was undertaken in patients with sarcoidosis to further substantiate our hypothesis that TRACP5a protein is a biomarker for macrophages in other chronic inflammatory diseases. Methods: Immunohistochemical staining for TRACP5a and CD68 was performed in tissues of 19 patients with sarcoidosis. We also measured circulating TRACP5a protein and other inflammation biomarkers including interkeukin-6, angiotensin-converting enzyme, and C-reactive protein in 13 patients. Twenty healthy age-matched nonsmoking individuals were used as the reference group. Results: All sarcoidosis tissues showed strong staining for TRACP5a and CD68 in the non-caseating granulomatous lesions and localized specifically to MΦ, multinucleate giant cells, and epithelioid MΦ. Serum TRACP5a protein was elevated significantly in active sarcoidosis patients compared with the control group, and levels fluctuated with disease activity in one patient studied longitudinally. Conclusion: TRACP5a protein is expressed abundantly in the granulomatous tissues and may be elevated in a significant proportion of sarcoidosis patients. These findings further support our hypothesis that serum TRACP5a is derived from systemic inflammatory MΦ and thereby may be a biomarker of inflammation for sarcoidosis and also reflect its disease activity.

AB - Background/Purpose: Tartrate-resistant acid phosphatase (TRACP) 5a is expressed strongly in inflammatory macrophages (MΦ). Serum TRACP5a is elevated in rheumatoid arthritis patients with extra-articular manifestations of rheumatoid nodules, in a percentage of patients with end-stage chronic kidney disease, and may be a risk marker for acute myocardial infarction. This proof-of-concept study was undertaken in patients with sarcoidosis to further substantiate our hypothesis that TRACP5a protein is a biomarker for macrophages in other chronic inflammatory diseases. Methods: Immunohistochemical staining for TRACP5a and CD68 was performed in tissues of 19 patients with sarcoidosis. We also measured circulating TRACP5a protein and other inflammation biomarkers including interkeukin-6, angiotensin-converting enzyme, and C-reactive protein in 13 patients. Twenty healthy age-matched nonsmoking individuals were used as the reference group. Results: All sarcoidosis tissues showed strong staining for TRACP5a and CD68 in the non-caseating granulomatous lesions and localized specifically to MΦ, multinucleate giant cells, and epithelioid MΦ. Serum TRACP5a protein was elevated significantly in active sarcoidosis patients compared with the control group, and levels fluctuated with disease activity in one patient studied longitudinally. Conclusion: TRACP5a protein is expressed abundantly in the granulomatous tissues and may be elevated in a significant proportion of sarcoidosis patients. These findings further support our hypothesis that serum TRACP5a is derived from systemic inflammatory MΦ and thereby may be a biomarker of inflammation for sarcoidosis and also reflect its disease activity.

KW - Inflammation

KW - Macrophage

KW - Sarcoidosis

KW - Tartrate-resistant acid phosphatase 5a

UR - http://www.scopus.com/inward/record.url?scp=84899914786&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899914786&partnerID=8YFLogxK

U2 - 10.1016/j.jfma.2012.07.033

DO - 10.1016/j.jfma.2012.07.033

M3 - Article

C2 - 24820632

AN - SCOPUS:84899914786

VL - 113

SP - 364

EP - 370

JO - Journal of the Formosan Medical Association

JF - Journal of the Formosan Medical Association

SN - 0929-6646

IS - 6

ER -